089 Breaking the cycle of chronic daily headache with a low-dose subcutaneous lignocaine and ketamine infusion
نویسندگان
چکیده
منابع مشابه
Comparative study on the impact of low-dose ketamine with midazolam and with low-dose midazolam with ketamine to prevent shivering after spinal anesthesia
Introduction: Shivering is one of the complications of spinal anesthesia. There are various methods to control this shivering. In this research we opted to study the effects of two different combination doses of ketamine and midazolam on the prevention of shivering after spinal anesthesia. Material and methods: Methods:The study was a double-blind clinical trial performed on 120 patients who w...
متن کاملPsychomimetic reactions after low-dose ketamine infusion. Comparison with neuroleptanaesthesia.
Low-dose ketamine anaesthesia was compared with neuroleptanaesthesia, in respect of immediate and longer-term psychomimetic reactions, in 40 female patients undergoing elective gynaecological surgery. Qualitatively, but not quantitatively, different psychomimetic reactions occurred in both groups. In the neurolept group the predominant complaint was of a dissociative nature, reported after 24 h...
متن کاملA Randomized Trial of Low-Dose Ketamine and Lignocaine Infiltration for Laparo- Caecectomy in Layer Chickens
This study compared the anaesthetic effects of intramuscular injection of Ketamine (K) (15 mg/kg) with intramuscular injection of Ketamine (K) (15 mg/kg) and Lignocaine (L) (4 mg/kg) infiltration for laparocaecectomy in 12 layer chickens (1.1±0.06 Kg) randomized into two groups (K, 5 chickens and KL, 7 chickens). The duration of recumbency of the K-L group (100.3±16.4 min) was significantly lon...
متن کاملDaily subcutaneous ultra-low-dose interleukin 2 with daily low-dose interferon-alpha in patients with advanced renal cell carcinoma.
A limited institution Phase II pilot study was performed using a very low-dose combination of daily s.c. interleukin (IL)-2 with IFN-alpha-2b in patients with advanced renal cancer in an attempt to duplicate or increase the response documented with higher dose schedules without the attendant toxicity profile. We selected a dose of IL-2 with documented immunological activity and combined it with...
متن کاملBreaking the cycle of medication overuse headache.
When patients who have frequent, disabling migraines take medications to relieve their symptoms, they run the risk that the attacks will increase in frequency to daily or near-daily as a rebound effect comes into play. This pattern, called medication overuse headache, is more likely to happen with butalbital and opioids than with migraine-specific drugs, as partial responses lead to recurrence,...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Neurology, Neurosurgery & Psychiatry
سال: 2019
ISSN: 0022-3050,1468-330X
DOI: 10.1136/jnnp-2019-anzan.77